Information, Networks and Rewards to Optimise Adherence to Diabetic Services (INROADS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03804970 |
|
Recruitment Status :
Completed
First Posted : January 15, 2019
Last Update Posted : March 19, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Diabetes | Behavioral: cash rewards for the fellow up Behavioral: Showing retinal photos to participants Behavioral: SMS reminders for participants and their family Behavioral: Watching brief video and basic explanation for disease Behavioral: Having the Diabetic Club | Not Applicable |
Background: Diabetes affects some 10% of rural-dwellers in southern China. Demand for care of both diabetes and DR is low in this population: Only 25% are in care for diabetes (vs 100% of a matched urban cohort), 0% were being treated for DR (vs 55% of the urban cohort) and 31% said they were likely/very likely to accept diabetic eyecare when it was described to them (vs 78% of the urban group). A simple intervention of informational SMS reminders could significantly increase knowledge about DR and satisfaction with care among rural dwellers, while tripling their compliance with scheduled eye examinations. However, even in the group receiving the SMS reminders, over half failed to present for exams. More effective interventions are needed.
Participants: All the participants with treated diabetes or HbA1c >=6.5% from the Guangdong (Yangjiang) centre of our population-based Rural Diabetic Eye Disease Survey. They must be aged 50-90 years, own a cell phone (ownership is > 95% in the area), have no mobility limitations precluding routine clinic visits or bilateral blindness (<6/120), and be capable of giving informed consent.
Randomisation: To avoid contamination, we are clustering recruitment and randomisation at the level of village and inviting participants in the two study groups to the Yangjiang eye screening centre for follow-up on different clinic days. Block randomization, at village level, will be balanced by the distribution of education levels and travel times from screening centre.
Intervention. All groups will be offered a brief video, already created and piloted, explaining basic information about diabetes and diabetic eye disease. The Intervention group will also receive (i) non-cash rewards (free eye care and modest mobile phone top ups in return for attendance at retinopathy screenings), the value of which will increase with the risk of vision loss (based on existing level of eye disease and HbA1c). (ii) Informational reminders delivered by SMS text 1 day and 1 week prior to scheduled eye exams. In keeping with health economic research,3 the reminders will emphasize anticipated regret: "Your next eye screening visit is next week, on dd/mm/yy. If you miss your eye screening visit, you might regret this if you subsequently lose your vision."; and (iii) peer and village health worker (VHW) networking (supported by the existing Orbis CREST project). Peer supporters will be a nominated family member or friend who has regular contact with the patient and a VHW or a community member with diabetes who has been trained to run monthly group educational sessions in the local village on optimum self-care and self-management of diabetes/DR. An important function of the family member or peer supporter is also to re-inforce the SMS informational reminders before the scheduled clinic visit.
Primary outcome measure: Proportion of scheduled eye care visits attended over 1 year. Secondary outcomes, not the direct target of our intervention, but which might be improved by a behavioural spill-over effect, will include: follow-up HbA1c; medication adherence; retinopathy grade and visual acuity in the better seeing eye.
Power and sample size: Assuming an effect size d= 0.44, and an attrition of 15% over two years, a full trial of 412 patients (42 villages in each of the two groups and 206 patients per group) would have 90% power (two sided alpha error 0.05).
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 225 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Health Services Research |
| Official Title: | Information, Networks and Rewards to Optimise Adherence to Diabetic Services: "INROADS in China": A Randomized Trial |
| Actual Study Start Date : | August 15, 2019 |
| Actual Primary Completion Date : | August 30, 2020 |
| Actual Study Completion Date : | December 30, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention group
Cash rewards for the fellow up+SMS reminders for participants and their family+Showing retinal photos to participants+ Having the Diabetic Club+Watching brief video and basic explanation for disease
|
Behavioral: cash rewards for the fellow up
This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. Behavioral: Showing retinal photos to participants This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. Behavioral: SMS reminders for participants and their family This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. Behavioral: Having the Diabetic Club This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. |
|
Experimental: Adjusted intervention group
Cash rewards for the fellow up+SMS reminders for participants and their family+Showing retinal photos to participants+Having the Diabetic Club+Watching brief video and basic explanation for disease( But the intensity of intervention based on the severity of diabetic disease)
|
Behavioral: cash rewards for the fellow up
This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. Behavioral: Showing retinal photos to participants This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. Behavioral: SMS reminders for participants and their family This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. Behavioral: Having the Diabetic Club This is a multiple stimulus intervention study, and there are two intervention groups. One is the normal intervention group, and the other is the adjusted intervention group. The intensity of intervention in the latter group is based on the severity of diabetic disease. |
|
Active Comparator: Control group
Watching brief video and basic explanation for disease
|
Behavioral: Watching brief video and basic explanation for disease
This basic explanation will be offered by professional doctors or nurses. |
- Proportion of scheduled eye care visits attended over 1 year [ Time Frame: One year ]The visits will be recorded during the 1 year
- Follow-up HbA1c [ Time Frame: One year ]This outcome will be recorded in the baseline and end-line examination
- Proportion of scheduled endocrine care visits attended over 1 year [ Time Frame: One year ]The outcome will be recorded during the 1 year
- Retinopathy grade in the better seeing eye. [ Time Frame: One year ]This outcome will be recorded in the baseline and end-line examination
- Visual acuity in the better seeing eye. [ Time Frame: One year ]This outcome will be recorded in the baseline and end-line examination
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 50 Years to 90 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- They must be aged 50-90 years;
- Own a cell phone (ownership is > 95% in the area);
- Have no mobility limitations precluding routine clinic visits or bilateral blindness (<6/120);
- Be capable of giving informed consent.
Exclusion Criteria:
- Have other serious eye disease;
- Have mobility limitations precluding routine clinic visits or bilateral blindness (<6/120).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03804970
| China, Guangdong | |
| Yangxi hospital | |
| Yangjiang, Guangdong, China | |
| Principal Investigator: | Nathan Congdon, MD | Zongshan Ophthalmic Center | |
| Principal Investigator: | Wenyong Huang, MD | Zongshan Ophthalmic Center | |
| Study Director: | Chunhui Chen | Yangxi People hospital, Guangdong | |
| Study Chair: | Congyao Wang | Zongshan Ophthalmic Center |
| Responsible Party: | Congdon Nathan, Professor of Preventative Ophthalmology, Sun Yat-sen University |
| ClinicalTrials.gov Identifier: | NCT03804970 |
| Other Study ID Numbers: |
ZOC-INROADS |
| First Posted: | January 15, 2019 Key Record Dates |
| Last Update Posted: | March 19, 2021 |
| Last Verified: | January 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Diabetes follow-up Diabetic retinopathy |
Diabetic teaching SMS rewards |

